Total Payments
$23,784
2024 Payments
$3,551
Companies
43
Transactions
1,129
Medicare Patients
1,169
Medicare Billing
$234,604
Payment Breakdown by Category
Food & Beverage$16,681 (70.1%)
Other$6,250 (26.3%)
Education$687.79 (2.9%)
Gifts$164.82 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,681 | 1,099 | 70.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,250 | 5 | 26.3% |
| Education | $687.79 | 20 | 2.9% |
| Gift | $164.82 | 5 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $5,000 | 4 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $1,999 | 95 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,573 | 115 | $0 (2024) |
| ABBVIE INC. | $1,368 | 110 | $0 (2024) |
| Validus Pharmaceuticals LLC | $1,257 | 39 | $0 (2023) |
| Eli Lilly and Company | $1,250 | 1 | $0 (2019) |
| Lundbeck LLC | $970.38 | 65 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $871.22 | 44 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $691.19 | 61 | $0 (2022) |
| Allergan, Inc. | $602.03 | 57 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,551 | 226 | ABBVIE INC. ($445.61) |
| 2023 | $2,838 | 189 | AbbVie Inc. ($390.38) |
| 2022 | $2,579 | 202 | Teva Pharmaceuticals USA, Inc. ($371.89) |
| 2021 | $2,337 | 98 | Validus Pharmaceuticals LLC ($713.82) |
| 2020 | $567.72 | 27 | Teva Pharmaceuticals USA, Inc. ($149.56) |
| 2019 | $8,116 | 140 | Lilly USA, LLC ($5,000) |
| 2018 | $1,792 | 132 | Teva Pharmaceuticals USA, Inc. ($257.59) |
| 2017 | $2,004 | 115 | Otsuka America Pharmaceutical, Inc. ($306.43) |
All Payment Transactions
1,129 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/12/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: CNS | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: Central Nervous System | ||||||
| 12/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $6.71 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $16.60 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: ADHD | ||||||
| 12/04/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: CNS | ||||||
| 12/04/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: CNS | ||||||
| 12/04/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: ADHD | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $8.87 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: Central Nervous System | ||||||
| 11/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.86 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $17.53 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Neuropsychiatry | ||||||
| 11/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Neuroscience | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 300 | 1,242 | $117,199 | $73,670 |
| 2022 | 5 | 321 | 1,136 | $109,880 | $67,506 |
| 2021 | 4 | 294 | 1,027 | $93,171 | $54,745 |
| 2020 | 4 | 254 | 777 | $69,682 | $38,683 |
Total Patients
1,169
Total Services
4,182
Medicare Billing
$234,604
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 133 | 752 | $63,920 | $39,973 | 62.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 86 | 354 | $31,152 | $19,764 | 63.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 36 | 84 | $10,601 | $7,043 | 66.4% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 27 | 34 | $6,126 | $4,359 | 71.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 18 | 18 | $5,400 | $2,531 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 122 | 619 | $52,615 | $32,620 | 62.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 95 | 316 | $27,148 | $16,702 | 61.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 48 | 127 | $14,622 | $9,099 | 62.2% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Office | 2022 | 33 | 51 | $8,595 | $5,561 | 64.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 23 | 23 | $6,900 | $3,524 | 51.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 107 | 573 | $48,705 | $29,915 | 61.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 123 | 309 | $26,265 | $13,123 | 50.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 43 | 106 | $11,766 | $7,212 | 61.3% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2021 | 21 | 39 | $6,435 | $4,495 | 69.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 103 | 539 | $45,815 | $24,611 | 53.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 96 | 156 | $13,145 | $7,592 | 57.8% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 32 | 52 | $5,772 | $3,728 | 64.6% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2020 | 23 | 30 | $4,950 | $2,752 | 55.6% |
About Dr. Herman Barb, MD
Dr. Herman Barb, MD is a Psychiatry healthcare provider based in Turnersville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225117682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Herman Barb, MD has received a total of $23,784 in payments from pharmaceutical and medical device companies, with $3,551 received in 2024. These payments were reported across 1,129 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($16,681).
As a Medicare-enrolled provider, Barb has provided services to 1,169 Medicare beneficiaries, totaling 4,182 services with total Medicare billing of $234,604. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Turnersville, NJ
- Active Since 11/04/2006
- Last Updated 01/07/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225117682
Products in Payments
- CYMBALTA (Drug) $6,250
- VRAYLAR (Drug) $1,970
- REXULTI (Drug) $1,882
- Equetro (Drug) $1,257
- AUSTEDO (Drug) $977.70
- JORNAY PM (Drug) $686.82
- LATUDA (Drug) $673.57
- CAPLYTA (Drug) $634.88
- APLENZIN (Drug) $556.35
- Dyanavel XR (Drug) $511.49
- INGREZZA (Drug) $496.50
- Austedo XR (Drug) $467.97
- TRINTELLIX (Drug) $429.00
- Adzenys XR-ODT (Drug) $416.54
- QELBREE (Drug) $405.49
- NUEDEXTA (Drug) $403.43
- SPRAVATO (Drug) $379.95
- Auvelity (Drug) $365.17
- ARISTADA (Drug) $340.69
- ABILIFY MYCITE (Drug) $306.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.